These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10577274)

  • 1. Cerebrospinal fluid levels of biotin in various neurological disorders.
    Anagnostouli M; Livaniou E; Nyalala JO; Evangelatos G; Zournas C; Ithakissios DS; Papageorgiou C
    Acta Neurol Scand; 1999 Jun; 99(6):387-92. PubMed ID: 10577274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive time-resolved immunofluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Application to multiple sclerosis and other neurological diseases.
    Osman I; Gaillard O; Meillet D; Bordas-Fonfrède M; Gervais A; Schuller E; Delattre J; Legrand A
    Eur J Clin Chem Clin Biochem; 1995 Jan; 33(1):53-8. PubMed ID: 7756441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of biotin levels in cerebrospinal fluid samples.
    Livaniou E; Nyalala JO; Anagnostouli M; Papageorgiou C; Evangelatos GP; Ithakissios DS
    J Pharm Biomed Anal; 1999 Dec; 21(4):875-9. PubMed ID: 10701954
    [No Abstract]   [Full Text] [Related]  

  • 5. KFLC Index utility in multiple sclerosis diagnosis: Further confirmation.
    Pieri M; Storto M; Pignalosa S; Zenobi R; Buttari F; Bernardini S; Centonze D; Dessi M
    J Neuroimmunol; 2017 Aug; 309():31-33. PubMed ID: 28601282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
    Rawes JA; Calabrese VP; Khan OA; DeVries GH
    Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders.
    Kulakowska A; Drozdowski W; Sadzynski A; Bucki R; Janmey PA
    Eur J Neurol; 2008 Jun; 15(6):584-8. PubMed ID: 18474076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders.
    Kapaki E; Segditsa J; Papageorgiou C
    Acta Neurol Scand; 1989 May; 79(5):373-8. PubMed ID: 2545071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.
    Trentini A; Castellazzi M; Romani A; Squerzanti M; Baldi E; Caniatti ML; Pugliatti M; Granieri E; Fainardi E; Bellini T; Cervellati C
    J Neurol Sci; 2017 Jun; 377():133-136. PubMed ID: 28477683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid proteins and serum immunoglobulins. Occurrence in multiple sclerosis and other neurological diseases: comparative measurement of gamma-globulin and the IgG class.
    Fischer-Williams M; Roberts RC
    Arch Neurol; 1971 Dec; 25(6):526-34. PubMed ID: 4107216
    [No Abstract]   [Full Text] [Related]  

  • 12. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL; Muls N; van Pesch V
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
    Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C
    Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligoclonal IgG bands in cerebrospinal fluid. Principles for demonstration and interpretation based on findings in 1114 neurological patients.
    Kostulas VK; Link H; Lefvert AK
    Arch Neurol; 1987 Oct; 44(10):1041-4. PubMed ID: 3632376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukotrienes and neurological diseases].
    Irkeç C; Ercan S; Irkeç M
    Mikrobiyol Bul; 1989 Oct; 23(4):342-7. PubMed ID: 2488942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequency of chromosome aberrations in long-term cultured cerebrospinal fluid lymphocytes of patients with multiple sclerosis.
    Sandberg-Wollheim M; Kristoffersson U; Mandahl N; Högstedt B
    J Neurol Sci; 1991 Mar; 102(1):46-50. PubMed ID: 1856732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase II in the cerebrospinal fluid: its value as a disease marker.
    Parkkila AK; Parkkila S; Reunanen M; Niemelä O; Tuisku S; Rautakorpi I; Rajaniemi H
    Eur J Clin Invest; 1997 May; 27(5):392-7. PubMed ID: 9179546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification and regulation of the adipokines resistin and progranulin in human cerebrospinal fluid.
    Berghoff M; Hochberg A; Schmid A; Schlegel J; Karrasch T; Kaps M; Schäffler A
    Eur J Clin Invest; 2016 Jan; 46(1):15-26. PubMed ID: 26509463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders.
    Meyne F; Gloeckner SF; Ciesielczyk B; Heinemann U; Krasnianski A; Meissner B; Zerr I
    J Alzheimers Dis; 2009; 17(4):863-73. PubMed ID: 19542614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis.
    Aasly J; Gårseth M; Sonnewald U; Zwart JA; White LR; Unsgård G
    Acta Neurol Scand; 1997 Jan; 95(1):9-12. PubMed ID: 9048978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.